07/10/2026
If you’ve been following along on my platform over the past few months, you’ll know we’ve spent a lot of time unpacking the changing landscape of child health—especially the big shifts happening in private immunisation.
It remains one of the most common questions parents ask when sitting across from me in consulting rooms. Paediatrics is moving into an incredible era of preventive care, and parents navigating the private vaccination schedule often ask about key additions we’ve frequently highlighted here: Bexsero for Meningococcal B, alongside ongoing discussions around RSV and targeted protection like Beyfortus.
Keeping track of all these medical terms and options can feel overwhelming!
Let’s revisit how these fit into keeping our little ones safe:
🧠 1. Meningococcal B (Bexsero): Closing an Important Gap
As we’ve discussed before, invasive meningococcal disease is fast-moving and while standard schedules cover a lot of ground, adding the MenB vaccine gives robust protection against a particularly aggressive bacterial strain.
🦠 2. RSV & Beyfortus: Monoclonal antibody choices like Beyfortus work by giving infants immediate, passive immunity—delivering ready-made antibodies right before or during peak season. It has completely transformed how we protect vulnerable infants and premature babies from severe lung infections.
💡 The Big Picture:
Immunisation isn't just about ticking boxes on a card; it’s about evolving science giving us sharper tools to shield growing bodies.
Every child’s health journey, lifestyle and risk profile is unique.
💬 Parents, have you been keeping up with these evolving options on the private vaccination schedule? If you're wondering how or when to layer these extra shields into your little one’s routine, chat to your child's Paediatrician at your next visit!
